Skip to main content
Clinical Trials/CTRI/2018/05/013843
CTRI/2018/05/013843
Not yet recruiting
Phase 4

Comparative clinical and ultrasonographic evaluation of the efficiency of Placentrex with Dexamethasone & Hyaluronidase with Dexamethasone in the treatment of Oral Submucous Fibrosis- A randomized Control Trial

Dr Sosa George0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Clinically Diagnosed cases of Oral Submucous Fibrosis
Sponsor
Dr Sosa George
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Sosa George

Eligibility Criteria

Inclusion Criteria

  • 1\)Individuals clinically diagnosed with Oral Submucous Fibrosis with palpable bands in the oral cavity
  • 2\)OSMF patients with mouth opening greater than 25mm
  • 3\)Individuals with willingness to quit the habit that caused the disease
  • 4\)Individuals willingly consenting to take part in the study
  • 5\)No previous history of treatment for oral submucous fibrosis
  • 6\)no other concurrent oral lesions

Exclusion Criteria

  • 1\)Patients who are unwilling to quit the habit that caused the disease.
  • 2\)Patients unwilling to consent for the study.
  • 3\)Previously treated Oral Submucous Fibrosis.
  • 4\)Currently under treatment for Oral Submucous Fibrosis.
  • 5\)Presence of other concurrent oral premalignant lesions.
  • 6\)Health status which makes the patient not a feasible candidate for the trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials